Please login to the form below

Not currently logged in
Email:
Password:

Gentium

This page shows the latest Gentium news and features for those working in and with pharma, biotech and healthcare.

Jazz Pharma bags FDA approval for rare disease drug

Jazz Pharma bags FDA approval for rare disease drug

Jazz acquired Defitelio as part of its $1bn purchase of Italy's Gentium in 2013.

Latest news

  • Jazz offers $1bn for Italy's Gentium Jazz offers $1bn for Italy's Gentium

    Shares in Nasdaq-listed Gentium closed just above $55.65 the day before the deal was announced. ... 10m. Gentium also has a small business unit selling active pharmaceutical ingredients (APIs) which contributed the bulk of the non-Defitelio turnover.

  • Gentium expects EMA rejection for defibrotide Gentium expects EMA rejection for defibrotide

    Gentium is expecting the European Medicines Agency (EMA) to turn down its investigational medicine defibrotide for a liver condition associated with stem cell transplantation. ... Dr Khalid Islam, president and CEO of Gentium, said the company was

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics